Related Experiment Videos
Growth potential and left ventricular diastolic function in cardiomyoplasty
1Department of Cardiovascular Surgery, Jichi Medical School, Tochigi, Japan.
The Annals of Thoracic Surgery
|May 22, 1998
Summary
Dynamic cardiomyoplasty shows potential for pediatric heart failure treatment. Studies indicate wrapped latissimus dorsi muscle flaps grow, and diastolic function remains unimpaired, suggesting safety for children.
Area of Science:
- Cardiovascular Surgery
- Pediatric Cardiology
- Regenerative Medicine
Background:
- Dynamic cardiomyoplasty is an experimental surgical procedure for advanced heart failure.
- Clinical outcomes suggest potential applicability in pediatric patients.
- This study investigates the impact of dynamic cardiomyoplasty on cardiac growth.
Purpose of the Study:
- To evaluate the relationship between dynamic cardiomyoplasty and heart growth in a pediatric model.
- To assess the functional and morphological changes in the heart and latissimus dorsi muscle after cardiomyoplasty.
Main Methods:
- Six young beagles underwent dynamic cardiomyoplasty without electrical stimulation.
- Five beagles served as a control group, undergoing median sternotomy and pericardiotomy.
- Cardiac and muscle weights, pressure-volume relationships, and histological changes were assessed after six months.
Main Results:
- Wrapped latissimus dorsi muscles showed growth (33 +/- 3 g), while unwrapped muscles were heavier (68 +/- 5 g).
- Heart weights were comparable between the cardiomyoplasty (82 +/- 3 g) and control (89 +/- 7 g) groups.
- Left ventricular maximum elastance and diastolic function were not significantly different between groups; however, fat infiltration and atrophy were noted in the cardiomyoplasty group's muscle flaps.
Conclusions:
- Wrapped latissimus dorsi muscle flaps demonstrated growth post-dynamic cardiomyoplasty.
- Diastolic cardiac function was not compromised by the procedure.
- These findings suggest dynamic cardiomyoplasty may be a potentially safe surgical option for children with heart failure.